These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 6627745)
1. Evidence for a functional central dopaminergic insufficiency in the spontaneously hypertensive rat. Hutchinson JS; DiNicolantonio R; Veroni M; Cleverdon M Clin Exp Pharmacol Physiol; 1983; 10(3):311-4. PubMed ID: 6627745 [TBL] [Abstract][Full Text] [Related]
2. Involvement of dopamine in development of hypertension in spontaneously hypertensive rat: effect of carbidopa, inhibitor of peripheral dopa decarboxylase. Yoshimura M; Kambara S; Takahashi H; Okabayashi H; Ijichi H Clin Exp Hypertens A; 1987; 9(10):1585-99. PubMed ID: 3677444 [TBL] [Abstract][Full Text] [Related]
3. Effect of l-dopa on sympathetic nerve activity and blood pressure in the spontaneously hypertensive rat. Judy WV; Watanabe AM; Henry DP; Besch HR; Aprison B Circ Res; 1978 Jul; 43(1):24-8. PubMed ID: 657456 [TBL] [Abstract][Full Text] [Related]
4. The actions of dopamine on the blood pressure and heart rate of conscious hypertensive rats: evidence for reduced dopaminergic activity in rats of the Japanese strains. Mok JS; Sim MK Clin Exp Hypertens A; 1987; 9(10):1615-35. PubMed ID: 3677445 [TBL] [Abstract][Full Text] [Related]
5. Effect of the intracerebroventricular injection of dopamine on blood pressure in the spontaneously hypertensive rat. Kawabe H; Kondo K; Saruta T Clin Exp Hypertens A; 1983; 5(10):1703-16. PubMed ID: 6667557 [TBL] [Abstract][Full Text] [Related]
6. CBF response to L-dopa influenced by peripheral decarboxylase inhibitor and serotonin in conscious SHR-SP, SHR-SR and WK rats. Skolasinska K; Kihara M; Horie R; Yamori Y Clin Exp Pharmacol Physiol; 1982; 9(6):631-7. PubMed ID: 7166007 [TBL] [Abstract][Full Text] [Related]
7. Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats. Yoshimura M; Kambara S; Okabayashi H; Takahashi H; Ijichi H Clin Exp Hypertens A; 1987; 9(7):1141-57. PubMed ID: 3621632 [TBL] [Abstract][Full Text] [Related]
8. Altered tonic L-3,4-dihydroxyphenylalanine systems in the nucleus tractus solitarii and the rostral ventrolateral medulla of spontaneously hypertensive rats. Yue JL; Okumura Y; Miyamae T; Ueda H; Misu Y Neuroscience; 1995 Jul; 67(1):95-106. PubMed ID: 7477914 [TBL] [Abstract][Full Text] [Related]
9. Chronic effects of central and systemic administration of losartan on blood pressure and baroreceptor reflex in spontaneously hypertensive rats. Kawano Y; Yoshida K; Matsuoka H; Omae T Am J Hypertens; 1994 Jun; 7(6):536-42. PubMed ID: 7917152 [TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of spontaneously hypertensive rats to the hypothermic effect of dopaminergic drugs. Martin JR; Quock RM Life Sci; 1980 Jul; 27(3):253-8. PubMed ID: 7401934 [No Abstract] [Full Text] [Related]
11. Pathophysiological role of dopamine on the development of hypertension in rats. Yoshimura M; Kambara S; Okabayashi H; Ikegaiki I; Matsuzawa M; Suga K; Takahashi H; Ijichi H Jpn Circ J; 1987 Oct; 51(10):1226-31. PubMed ID: 3430692 [TBL] [Abstract][Full Text] [Related]
12. Evidence for dopamine as an inhibitor of vasoprotein release in man. Lightman SL; Forsling M Clin Endocrinol (Oxf); 1980 Jan; 12(1):39-46. PubMed ID: 7379312 [TBL] [Abstract][Full Text] [Related]
13. Evidence for L-dopa systems responsible for cardiovascular control in the nucleus tractus solitarii of the rat. Kubo T; Yue JL; Goshima Y; Nakamura S; Misu Y Neurosci Lett; 1992 Jun; 140(2):153-6. PubMed ID: 1501771 [TBL] [Abstract][Full Text] [Related]
14. Effect of dopamine, L-dopa, carbidopa and L-dopa/carbidopa on arthus and delayed hypersensitivity skin reactions in the rat. Horvat J; Stojić Z; Janković BD Int J Neurosci; 1991 Jul; 59(1-3):199-203. PubMed ID: 1837790 [TBL] [Abstract][Full Text] [Related]
15. Role of dopamine in the inhibition of vasopressin secretion by L-dopa in carbidopa-treated dogs. Reid IA; Chou L; Chang D; Keil LC Hypertension; 1986 Oct; 8(10):890-6. PubMed ID: 2875946 [TBL] [Abstract][Full Text] [Related]
16. Effects of intraventricular and intraspinal 6-hydroxydopamine on blood pressure of apontaneously hypertensive rats. Kubo T; Hashimoto M Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):166-76. PubMed ID: 666457 [TBL] [Abstract][Full Text] [Related]
17. Central effects of endothelin and its antagonists on sympathetic and cardiovascular regulation in SHR-SP. Nakamura K; Sasaki S; Moriguchi J; Morimoto S; Miki S; Kawa T; Itoh H; Nakata T; Takeda K; Nakagawa M J Cardiovasc Pharmacol; 1999 Jun; 33(6):876-82. PubMed ID: 10367590 [TBL] [Abstract][Full Text] [Related]
18. Role of dopamine in the development of spontaneous hypertension. van den Buuse M; Versteeg DH; de Jong W Hypertension; 1984; 6(6 Pt 1):899-905. PubMed ID: 6519747 [TBL] [Abstract][Full Text] [Related]
19. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors. Fine SA; Frohman LA J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585 [TBL] [Abstract][Full Text] [Related]
20. Dopamine and L-dopa potentiation of pressor responses to norepinephrine in isolated perfused rat kidneys. Lam BK; Stier CT; Wynn NC; Itskovitz HD J Cardiovasc Pharmacol; 1986; 8(3):554-8. PubMed ID: 2425172 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]